FASLG and cancer: In the cancer subgroup, 60% of the patients had at least one positive aPL, with significantly more patients being positive for aβ2GPI IgG compared with the non-cancer subgroup-<i>p</i> = 0.03, OR = 2.23 (1.02-4.88).